-
1
Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT)
Published 2023Get full text
Journal Article -
2
-
3
-
4
DOK3 promotes atopic dermatitis by enabling the phosphatase PP4C to inhibit the T cell signaling mediator CARD11
Published 2024Get full text
Journal Article -
5